Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Hasbani: We Developed a Comprehensive Health System so as not to Exclude any Citizen from the Universal Coverage

 
NNA- The administration and justice committee held a meeting presided by Deputy Robert Ghanem in the presence of Deputy Prime Minister Health Minister Ghassan Hasbani and deputies: Hani Kobaisy, Elie Aoun, Serge Torsarkisian, Atef Majdalani, Ghassan Moukhayber, Nawaf Mousawi, the representatives of Health Ministry Fadi Mosallem and the Ministry of Social Affairs Adnan Naser Eddine, Director General of the National Social Security Fund Dr. Muhammad Karaki, Head of NSSF Diwan Chawki Abou Nassif, the representative of the Ministry of Finance Nahla Boustani, the President of the General Confederation of Lebanese Workers Bechara Asmar.

Ghanem

“This is the eighth meeting of the administration and justice committee to study the so-called visa coverage card; the mandatory universal healthcare coverage suggested by Dr Atef Majdalani and studied by the Health committee. When H.E. Hasbani became Health Minister, he asked that this subject be more comprehensive. A study was conducted to include the majority of the Lebanese citizens,” stated the committee’s president.

Hasbani

“I would like to thank and congratulate the administration and justice committee for discussing the proposal of the law submitted by Deputy Atef Majdalani. The Ministry of Public Health made observations based on a recent study this year on the health coverage or the mandatory universal health care. The detailed study with experts includes many observations made on this subject to develop the system so as not to exclude any citizen from the universal coverage; primary health care, inpatient and outpatient services,” outlined Hasbani.

Majdalani

“I would like to thank my colleague Mr. Robert Ghanem, the president of the administration and justice committee for his help and seriousness in scheduling the meetings of the committee and contribution in the discussions. I thank as well Health Minister Ghassan Hasbani for the amendments of Health Ministry to expand the network of social and health solidarity in the proposal of the law we suggested in 2013,” said Majdalani.
    3
ATC Name B/G Ingredients Dosage Form Price
R03BA05 FLIXOTIDE EVOHALER B Fluticasone propionate - 50mcg/actuation 50mcg/actuation Inhalation suspension 671,921 L.L
B03AC FERAPPLIC G Iron trivalent (ferric carboxymaltose) - 500mg/10ml 500mg/10ml Injectable dispersion 34,231,559 L.L
J05AB16 FLEXIVIR G Remdesivir - 50mg 50mg Injectable lyophilised powder for solution 4,837,833 L.L
G03GA04 FOSTIMON BioHuman Urofollitropin - 150IU 150IU Injectable lyophilised powder for solution+diluent 36,347,120 L.L
G03GA04 FOSTIMON BioHuman Urofollitropin - 75IU 75IU Injectable lyophilised powder for solution+diluent 15,744,000 L.L
A16AB04 FABRAZYME BioTech Agalsidase beta - 35mg 35mg Injectable powder for concentrate for solution 295,038,213 L.L
A16AB04 FABRAZYME BioTech Agalsidase beta - 35mg 35mg Injectable powder for concentrate for solution L.L
J01DD02 FORTECARE G Ceftazidime - 1g 1g Injectable powder for solution 10,011,695 L.L
L02BX02 FIRMAGON B Degarelix (acetate) - 80mg 80mg Injectable powder for solution+diluent 13,361,635 L.L
L02BX02 FIRMAGON B Degarelix (acetate) - 120mg 120mg Injectable powder for solution+diluent 24,325,802 L.L
B02BB01 FIBRYGA BioHuman Fibrinogen, human - 1g 1g Injectable powder for solution+solvent 40,915,563 L.L
B02BD03 FEIBA BioHuman Factor VIII Inhibitor bypassing fraction - 500IU 500U (50U/ml) Injectable powder for solution+solvent 40,480,699 L.L
B02BD03 FEIBA BioHuman Factor VIII Inhibitor bypassing fraction - 1000IU 1000U (50U/ml) Injectable powder for solution+solvent 79,869,612 L.L
L02BA03 FASLODEX B Fulvestrant - 250mg/5ml 250mg/5ml Injectable solution L.L
H05AA02 FORTEO BioTech Teriparatide - 250mcg/ml 20mcg/80mcl Injectable solution 24,834,241 L.L
R03DX10 FASENRA B Benralizumab - 30mg 30mg Injectable solution L.L
C03CA01 FRURETIC G Furosemide - 20mg/2ml 20mg/2ml Injectable solution 2,600,655 L.L
C03CA01 FUROLIX G Furosemide - 20mg/2ml 20mg/2ml Injectable solution 1,612,611 L.L
C03CA01 FUROSEMIDE RENAUDIN G Furosemide (sodium) - 20mg/2ml 20mg/2ml Injectable solution 451,531 L.L
C03CA01 FUROSEMIDE SALF G Furosemide - 20mg/2ml 20mg/2ml Injectable solution 216,359 L.L
C03CA01 FUROSEMIDE RENAUDIN G Furosemide - 250mg/25ml 250mg/25ml Injectable solution 1,791,342 L.L
C03CA01 FUROSEMIDE S.A.L.F. G Furosemide - 250mg/25ml 250mg/25ml Injectable solution 919,188 L.L
L01BB05 FLUDARABINE PHOSPHATE NEAPOLIS G Fludarabine Dihydrogenophosphate - 50mg/2ml 50mg/2ml Injectable solution L.L
R03DX10 FASENRA B Benralizumab - 30mg 30mg Injectable solution 214,213,273 L.L
L02BA03 FASLODEX B Fulvestrant - 250mg/5ml 250mg/5ml Injectable solution 46,628,557 L.L
L02BA03 FULVESTRANT ARROW G Fulvestrant - 250mg/5ml 250mg/5ml Injectable solution 12,644,009 L.L
L02BA03 FULVESTRANT EVER PHARMA G Fulvestrant - 250mg/5ml 250mg Injectable solution 14,393,267 L.L
L02BA03 FUXRAN G Fulvestrant - 250mg/5ml 250mg/5ml Injectable solution 23,017,465 L.L
B03AC FER PANPHARMA G Iron (sucrose) - 100mg/5ml 100mg/5ml Injectable solution 2,315,441 L.L
S01JA01 FLUORESCEIN SODIUM USP IV G Fluorescein sodium - 10% 10% Injectable solution 1,198,595 L.L
    3
Sitemap
© Copyrights reserved to Ministry of Public Health 2026